Analyst firms · J.P. Morgan · GDRX

J.P. Morgan GDRX price target and rating history

GoodRx Holdings Inc. (GDRX) · Technology

J.P. Morgan rates GoodRx Holdings Inc. (GDRX) Overweight with a $10 price target, as of its latest action on Mar 1, 2024. It has published 3 rating actions on GDRX since March 2022, including 2 upgrades and 0 downgrades.

Current rating
Overweight
Price target
$10
Median target, all firms
Too few
Actions on GDRX
3

J.P. Morgan price target on GDRX

$10$9$82023202420252026
J.P. Morgan price target on GDRX, each point a stated target, March 2022 to March 2024. Targets before November 2022 (divided by 2) are adjusted for a stock split, going by the prior target J.P. Morgan restated.

Every J.P. Morgan rating on GDRX

How other firms rate GDRX

Each firm's latest rating and stated target in the last 12 months.

FirmRatingPrice targetDate
JefferiesHold$2.75Jan 22, 2026
BarclaysUnderweight$3Dec 9, 2025

Questions about J.P. Morgan and GDRX

What is J.P. Morgan's price target for GDRX?
J.P. Morgan's latest stated price target for GoodRx Holdings Inc. (GDRX) is $10, from its action on Mar 1, 2024.
What is J.P. Morgan's rating on GDRX?
J.P. Morgan rates GDRX Overweight, a bullish rating, as of Mar 1, 2024.
When did J.P. Morgan last change its view on GDRX?
On Mar 1, 2024, J.P. Morgan upgrades to Overweight from Neutral, price target $7 to $10.

More GDRX rating histories

All J.P. Morgan ratingsGDRX news and filingsEvery analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.